Researchers at Case Western Reserve University, University Hospitals, and Houston Methodist are embarking on a groundbreaking ...
The company shared interim results from an ongoing Phase II trial examining its recombinant antibody fusion protein.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback